Mozifor (Plerixafor) 24 mg / 1.2 ml
Mozifor is a hematopoietic stem cell mobilizer. Active ingredient: Plerixafor (24 mg / 1.2 ml).
Manufacturer: Hetero Healthcare (India). Generic equivalent of Mozobil.
Mechanism of Action:
Plerixafor is a reversible inhibitor of the CXCR4 chemokine receptor. It blocks the interaction between CXCR4 and SDF-1alpha, which "anchors" stem cells in the bone marrow. By breaking this bond, Mozifor releases stem cells into the bloodstream, allowing them to be collected for transplantation.
✅ Key Benefit: Increases the yield of CD34+ stem cells in patients who fail to mobilize enough cells with G-CSF alone.
Notice. The information on this page is for reference only and does not replace medical consultation. Always consult a healthcare professional and read the manufacturer's instructions before using any medicine. Self-medication may be dangerous. Information updated: 12.03.2026
What Customers Say
No reviews yet
Your review can be the first!